Reconstruction of 3D DIC Microscopy Images
Small Business Information
AUTOQUANT IMAGING, INC. (Currently Lickenbrock Technologies LLC)
877 25TH ST, WATERVLIET, NY, 12189
AbstractThe overall project objective is to develop a commercial software product to improve the resolution and allow for quantitative analysis of specimens imaged using differential interference contrast (DIC) microscopy, by reconstructing a map of the optical path length distribution. This will essentially enable a DIC microscope to operate as a "virtual" transmitted light interference microscope. Phase 1 has shown the feasibility of reconstructing both 2D and 3D biological specimens. This resolution improvement will allow sub-cellular components of sizes that are near, or just below, the microscope diffraction limit to be resolved. Among other advantages, the optical path length information will enable the dry mass of a cell to be quantified, and for the reconstructed data to be used with standard 3D visualization methods or for automated cell analysis. The Phase 2 objectives are to refine the algorithm development to a commercial level, including; integration of the reconstruction and deconvolution algorithms, and improvements in robustness and speed. The accuracy of the optical path length information will be verified using test targets and biological specimens with known characteristics. Additional 2D and 3D biological specimens will be captured and processed to analyze performance and establish the required imaging protocol. PROPOSED COMMERCIAL APPLICATIONS: DIC microscopy is a widely used modality for observing live specimens, and the instrument will be enhanced by the quantitative results produced by the reconstruction software. DIC could now be quantitatively used when photo-toxic epi-fluorescence is undesirable. 3D specimens can now be captured in DIC and volume rendered. Changes in cell growth can be tracked, which will benefit genetic engineering. Increases in resolution will enable analysis of structures beyond the optical diffraction limit.
* information listed above is at the time of submission.